Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Gene therapy for cocaine addiction

Sep. 25, 2018

Treatment with the novel GPR88 agonist RTI-13951-33 reduces alcohol intake in vivo

Sep. 21, 2018

Amygdala Neurosciences announces SEARCH phase II studies with ANS-6637

Sep. 20, 2018

NIDA award supports Ensysce's development of opioid overdose protection platform

Sep. 19, 2018

NIAAA to conduct phase II study of ANS-6637 for alcohol use disorder

Sep. 13, 2018

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Addicted to bile acids

Aug. 2, 2018

First cohort dosed in phase I study of OMS-527

July 18, 2018

The locus of alcohol's reward

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.